Canaccord Genuity Reiterates Buy Rating on TELA Bio, Inc. (TELA)

April 9, 2025 6:35 AM EDT Send to a Friend
Canaccord Genuity analyst Kyle Rose reiterated a Buy rating and $7.00 price target on TELA Bio, Inc. (NASDAQ: TELA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login